Fernando Aranda

ResearcherID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Venues

Oncoimmunology

Journal for immunotherapy of cancer

Nature communications

Cancers

Centro de Investigación Médica Aplicada

Centro de Investigación Médica Aplicada (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centro de Investigación Médica Aplicada Feb 17 2020

Spain

Staff Scientist :: Immunology and Immunotherapy

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Sep 01 2014 - Dec 29 2019

Spain

Senior Postdoctoral Researcher :: Immunoreceptors of Innata and Adaptative Response

Institut Gustave Roussy Sep 01 2013 - Aug 31 2014

France

Postdoctoral Researcher :: Apoptosis, Cancer & Immunology

Centro de Investigación Médica Aplicada Oct 01 2012 - Aug 31 2013

Spain

Postdoctoral Researcher :: Onco-Immunology Therapy

University of Navarra - CIMA Oct 01 2008 - Oct 01 2012

Spain

PhD Student :: Experimental Immunology

University of Navarra Oct 01 2008 - May 01 2012

Spain

Teaching Assistant :: Biochemistry Department

Hospital Virgen del Camino Oct 01 2006 - Jan 31 2007

Spain

Lab Technician :: Infectious Diseases and Immunity

Education History

Centro de Investigación Médica Aplicada

Spain

PHD :: Experimental Immunology

University of Navarra

Spain

MSC

University of Navarra

Spain

BSC

University of Navarra

Spain

BSC

Publications

Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Celia Gomar, Claudia Augusta Di Trani, Angela Bella, Leire Arrizabalaga, Jose Gonzalez-Gomariz, Myriam Fernandez-Sendin, Maite Alvarez, Joan Salvador Russo-Cabrera, Nuria Ardaiz, Fernando Aranda, Timo Schippers, Marisol Quintero, Ignacio Melero Bermejo, Klaus K Orlinger, Henning Lauterbach, Pedro Berraondo
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for immunotherapy of cancer 12 (4) (2024)
Ángela Bella, Ignacio Melero, Pedro Berraondo, Fernando Aranda
The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosis. Oncoimmunology 12 (1) (2023)
Ángela Bella, Ignacio Melero, Pedro Berraondo, Fernando Aranda
The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosis. Oncoimmunology 12 (1) (2023)
Ángela Bella, Leire Arrizabalaga, Claudia Augusta Di Trani, Jose Gonzalez-Gomariz, Celia Gomar, Joan Salvador Russo-Cabrera, Irene Olivera, Assunta Cirella, Myriam Fernandez-Sendin, Maite Alvarez, Alvaro Teijeira, Cigdem Atay, José Medina-Echeverz, Maria Hinterberger, Hubertus Hochrein, Ignacio Melero Bermejo, Pedro Berraondo, Fernando Aranda
Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis. Journal for immunotherapy of cancer 11 (11) (2023)
Claudia Augusta Di Trani, Assunta Cirella, Leire Arrizabalaga, Ángela Bella, Myriam Fernandez-Sendin, Joan Salvador Russo-Cabrera, Celia Gomar, Irene Olivera, Elizabeth Bolaños, José González-Gomariz, Maite Álvarez, Iñaki Etxeberria, Belen Palencia, Álvaro Teijeira, Ignacio Melero, Pedro Berraondo, Fernando Aranda
Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8 + T cells eradicates peritoneal metastases in mouse models. Oncoimmunology 12 (1) (2022)
Ángela Bella, Leire Arrizabalaga, Claudia Augusta Di Trani, Assunta Cirella, Myriam Fernandez-Sendin, Celia Gomar, Joan Salvador Russo-Cabrera, Inmaculada Rodríguez, José González-Gomariz, Maite Alvarez, Álvaro Teijeira, José Medina-Echeverz, Maria Hinterberger, Hubertus Hochrein, Ignacio Melero, Pedro Berraondo, Fernando Aranda
Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis. Oncoimmunology 11 (1) (2022)
Claudia Augusta Di Trani, Assunta Cirella, Leire Arrizabalaga, Ángela Bella, Myriam Fernandez-Sendin, Joan Salvador Russo-Cabrera, Celia Gomar, Irene Olivera, Elizabeth Bolaños, José González-Gomariz, Maite Álvarez, Iñaki Etxeberria, Belen Palencia, Álvaro Teijeira, Ignacio Melero, Pedro Berraondo, Fernando Aranda
Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8 + T cells eradicates peritoneal metastases in mouse models. Oncoimmunology 12 (1) (2022)
Claudia Augusta Di Trani, Assunta Cirella, Leire Arrizabalaga, Ángela Bella, Myriam Fernandez-Sendin, Joan Salvador Russo-Cabrera, Celia Gomar, Irene Olivera, Elizabeth Bolaños, José González-Gomariz, Maite Álvarez, Iñaki Etxeberria, Belen Palencia, Álvaro Teijeira, Ignacio Melero, Pedro Berraondo, Fernando Aranda
Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8 + T cells eradicates peritoneal metastases in mouse models. Oncoimmunology 12 (1) (2022)
Claudia Augusta Di Trani, Assunta Cirella, Leire Arrizabalaga, Ángela Bella, Myriam Fernandez-Sendin, Joan Salvador Russo-Cabrera, Celia Gomar, Irene Olivera, Elizabeth Bolaños, José González-Gomariz, Maite Álvarez, Iñaki Etxeberria, Belen Palencia, Álvaro Teijeira, Ignacio Melero, Pedro Berraondo, Fernando Aranda
Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8 + T cells eradicates peritoneal metastases in mouse models. Oncoimmunology 12 (1) (2022)
Ángela Bella, Claudia Augusta Di Trani, Myriam Fernandez-Sendin, Leire Arrizabalaga, Assunta Cirella, Alvaro Teijeira, José Medina-Echeverz, Ignacio Melero Bermejo, Pedro Berraondo, Fernando Aranda
Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications. Cancers 13 (5) (2021)
Aitziber Buque, Norma Bloy, Maria Perez-Lanzón, Kristina Iribarren, Juliette Humeau, Jonathan G Pol, Sarah Levesque, Laura Mondragon, Takahiro Yamazaki, Ai Sato, Fernando Aranda, Sylvère Durand, Alexandre Boissonnas, Jitka Fucikova, Laura Senovilla, David Enot, Michal Hensler, Margerie Kremer, Gautier Stoll, Yang Hu, Chiara Massa, Sylvia C Formenti, Barbara Seliger, Olivier Elemento, Radek Spisek, Fabrice Andre, Laurence Zitvogel, Suzette Delaloge, Guido Kroemer, Lorenzo Galluzzi
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature communications 11 (1) (2020)
María Velasco-de Andrés, Sergi Casadó-Llombart, Cristina Català, Alejandra Leyton-Pereira, Francisco Lozano, Fernando Aranda
Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents. Cells 9 (12) (2020)
Aitziber Buque, Norma Bloy, Maria Perez-Lanzón, Kristina Iribarren, Juliette Humeau, Jonathan G Pol, Sarah Levesque, Laura Mondragon, Takahiro Yamazaki, Ai Sato, Fernando Aranda, Sylvère Durand, Alexandre Boissonnas, Jitka Fucikova, Laura Senovilla, David Enot, Michal Hensler, Margerie Kremer, Gautier Stoll, Yang Hu, Chiara Massa, Sylvia C Formenti, Barbara Seliger, Olivier Elemento, Radek Spisek, Fabrice Andre, Laurence Zitvogel, Suzette Delaloge, Guido Kroemer, Lorenzo Galluzzi
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature communications 11 (1) (2020)
Marcos Vasquez, Marta Consuegra-Fernández, Fernando Aranda, Aitor Jimenez, Shirley Tenesaca, Myriam Fernandez-Sendin, Celia Gomar, Nuria Ardaiz, Claudia Augusta Di Trani, Noelia Casares, Juan Jose Lasarte, Francisco Lozano, Pedro Berraondo
Treatment of Experimental Autoimmune Encephalomyelitis by Sustained Delivery of Low-Dose IFN-α. Journal of immunology (Baltimore, Md. : 1950) 203 (3) (2019)
Marcos Vasquez, Inês Simões, Marta Consuegra-Fernández, Fernando Aranda, Francisco Lozano, Pedro Berraondo
Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1. European journal of immunology 47 (7) (2017)

Fernando Aranda.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Fernando Aranda